Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Maureen O'Brien

Associate Professor of Clinical Pediatrics

University of Cincinnati

United States

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacotherapy

70%

Immunology

20%

Pediatric Oncology

60%

Graft-versus-host Disease

40%

Cancer Therapy

30%

Targeted Therapy

30%

Pediatric Hematology

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles9

The Choice of Either Conventional Chemotherapy or Inotuzumab Ozogamicin as Bridging Regimen Does Not Appear To Impact Clinical Response to CD19-Directed CAR-T Therapy in Pediatric B-ALL

Article Link

Year:

2023

CD22low/Bcl-2high expression identifies poor response to inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia

Article Link

Year:

2023

Outcome of chimeric antigen receptor T-cell therapy following treatment with inotuzumab ozogamicin in children with relapsed or refractory acute lymphoblastic leukemia

Article Link

Year:

2023

Phase 1b study of carfilzomib with induction chemotherapy in pediatric relapsed/refractory acute lymphoblastic leukemia

Article Link

Year:

2022

Improving infectious adverse event reporting for children and adolescents enrolled in clinical trials for acute lymphoblastic leukemia: A report from the Children's Oncology Group

Article Link

Year:

2022

Phase II Trial of Inotuzumab Ozogamicin in Children and Adolescents With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: Children's Oncology Group Protocol AALL1621

Article Link

Year:

2022

Treatment of posttransplant lymphoproliferative disorder with poor prognostic features in children and young adults: Short‐course EPOCH regimens are safe and effective

Article Link

Year:

2021

Results of a phase 2, multicenter, single‐arm, open‐label study of lenalidomide in pediatric patients with relapsed or refractory acute myeloid leukemia

Article Link

Year:

2021

Defining the Optimal Treatment of First Relapse of Pediatric Relapsed Anaplastic Large-Cell Lymphoma: Clinical Trial Challenges for Rare Diagnoses

Article Link

Year:

2020

Collaborators11

Melinda Pauly

Assistant Professor

Emory University

UNITED STATES

Sumit Gupta

University of Toronto

CANADA

Robin Norris

Associate Professor

Cincinnati Children's Hospital Medical Center

UNITED STATES

Jennifer McNeer

Professor

University of Utah

UNITED STATES

Ernesto Diaz-Flores

University of California, San Francisco

UNITED STATES

Lynn Lee

Research Assistant Professor

Cincinnati Children's Hospital Medical Center

UNITED STATES

Franco Locatelli

Full Professor of Pediatrics

Catholic University of the Sacred Heart

ITALY

KRZYSZTOF KALWAK

MD, PhD, Prof.

Wroclaw Medical University

POLAND

Michael Burke

Associate Professor

Medical College of Wisconsin

UNITED STATES

KENICHI ISHIYAMA

Assistant professor

Kyoto University

JAPAN

Jeremy Rubinstein

Assistant Professor

Cincinnati Children's Hospital Medical Center

UNITED STATES

How do I reach out?

Meet Kite AI